United States · FDA National Drug Code directory
Venlafaxine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-196_f913aca4-ac1e-475d-80ed-f48c7c2666c5
- Product NDC
- 33342-196
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Venlafaxine hydrochloride
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171006
- Source listing expiry
- 20271231
Source-listed ingredients
- VENLAFAXINE HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (33342-196-07) · 33342-196-07
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (33342-196-10) · 33342-196-10
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (33342-196-11) · 33342-196-11
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (33342-196-15) · 33342-196-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →